PD-98059 PD98059 CAS: 167869-21-8

CAS NO: 167869-21-8
PD-98059 PD98059
Chemical Name: PD 98059
Molecular Formula: C16H13NO3
Formula Weight: 267.28
CAS No.: 167869-21-8
Description Review
Description

PD-98059 (also known as PD98059) is a chemical compound that is mainly used in scientific research to inhibit the activity of a specific type of enzyme. This inhibition has potential applications in treating certain medical conditions related to abnormal cell growth, such as cancer.

Chemical name: The chemical name of PD-98059 is 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one.

Molecular formula: The molecular formula of PD-98059 is C16H13NO3.

Formula weight: The molecular weight of PD-98059 is 267.28 g/mol.

CAS No: The CAS number of PD-98059 is 167869-21-8.

Top ten keywords from Google and synonyms:

  1. Cancer
  2. Mitogen-activated protein kinase (MAPK)
  3. Enzyme inhibitor
  4. Cell growth
  5. Signal transduction
  6. Tumor cells
  7. Cancer therapy
  8. Cell proliferation
  9. Oncology
  10. Apoptosis

Synonyms: • 2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one • Mitogen-activated protein kinase inhibitor PD-98059 • PD-98059 MAPK Inhibitor

Health benefits of this product: PD-98059 may have health benefits due to its ability to inhibit the activity of the enzyme mitogen-activated protein kinase (MAPK). This inhibition can potentially affect cellular processes related to abnormal cell growth, such as cell proliferation and apoptosis, making it a target for cancer therapy.

Potential effects: PD-98059 inhibits the activity of the enzyme mitogen-activated protein kinase (MAPK), which plays a role in various cellular processes like cell growth, differentiation, and survival. By inhibiting MAPK, PD-98059 can potentially affect these processes, leading to changes in cell behavior, including cell cycle arrest or apoptosis.

Product mechanism: PD-98059 inhibits the activity of the enzyme mitogen-activated protein kinase (MAPK) by binding to the ATP-binding site of the enzyme. MAPKs are involved in various cellular processes, including cell growth, differentiation, and survival. By inhibiting MAPK, PD-98059 can block these processes and potentially reduce abnormal cell growth.

Safety: PD-98059 is mainly used in scientific research and has not been approved for human use. Its safety in humans is not well established, and there may be potential side effects associated with its use. Individuals should seek advice from a healthcare professional before using PD-98059.

Side effects: The potential side effects of PD-98059 are not well-established as it is primarily used in scientific research. However, there may be potential risks associated with its use, including allergic reactions, toxicity, and effects on normal cell growth.

Dosing information: PD-98059 is mainly used in scientific research and dosing information is determined based on the specific experiment being performed. Individuals should consult with a qualified scientist or healthcare professional for guidance on appropriate dosing.

Conclusion: PD-98059 is a chemical compound that is commonly used in scientific research to inhibit the activity of the enzyme mitogen-activated protein kinase (MAPK). The inhibition of MAPK has potential applications in cancer therapy by affecting cellular processes related to abnormal cell growth. Although mainly used in scientific research, potential side effects and safety concerns should be taken into consideration if considering its use. Further studies are needed to determine the safety and efficacy of PD-98059 for human use

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code